{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:59:07Z","timestamp":1780084747044,"version":"3.54.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"am","delay-in-days":423,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103428","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:08:27Z","timestamp":1698786507000},"page":"103428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6102-014X","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Daudignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Penther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Chauzeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2023.103428_bib0001","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid tumours: lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.2008.07042.x","article-title":"Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma","volume":"141","author":"Nelson","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0003","doi-asserted-by":"crossref","first-page":"E319","DOI":"10.1002\/ajh.25967","article-title":"Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed\/refractory to chemotherapy","volume":"95","author":"Bossi","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2023.103428_bib0004","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3960\/jslrt.17023","article-title":"Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects","volume":"57","author":"Tsuyama","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.retram.2023.103428_bib0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","article-title":"Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas","volume":"140","author":"Salaverria","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0006","first-page":"3509","article-title":"Lymphomas expressing ALK fusion protein(s) other than NPM-ALK","volume":"94","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0007","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0008","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0009","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0012","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0013","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3324\/haematol.2022.281442","article-title":"ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study","volume":"108","author":"Sibon","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0014","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma","volume":"108","author":"Qiu","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0016","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0017","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"Double-hit\u201d of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0018","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.retram.2023.103428_bib0019","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41379-018-0134-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0021","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/blood.2020005372","article-title":"Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma","volume":"136","author":"Los-de Vries","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0022","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/tbj.14205","article-title":"Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway","volume":"27","author":"Quesada","year":"2021","journal-title":"Breast J"},{"key":"10.1016\/j.retram.2023.103428_bib0023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0024","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jmoldx.2021.04.013","article-title":"Detection of gene fusion transcripts in peripheral T-cell lymphoma using a multiplexed targeted sequencing assay","volume":"23","author":"Drieux","year":"2021","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.retram.2023.103428_bib0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MD.0b013e3181573059","article-title":"Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients","volume":"86","author":"Lachenal","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.retram.2023.103428_bib0026","first-page":"1108","article-title":"Update on recurrent mutations in angioimmunoblastic T-cell lymphoma","volume":"14","author":"Yu","year":"2021","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0027","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0028","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0029","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2023.103428_bib0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0031","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0032","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1101441","article-title":"PTCL, NOS: an update on classification, risk-stratification, and treatment","volume":"13","author":"Weiss","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.retram.2023.103428_bib0034","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ajh.24679","article-title":"Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia","volume":"92","author":"Hu","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2023.103428_bib0036","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/annonc\/mdx163","article-title":"Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)","volume":"28","author":"Jain","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.retram.2023.103428_bib0037","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.775363","article-title":"Advanced pathogenetic concepts in T-cell prolymphocytic leukemia and their translational impact","volume":"11","author":"Braun","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.retram.2023.103428_bib0039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.2023020401","article-title":"T-cell prolymphocytic leukemia\/lymphoma with TCRB::TCL1 translocation","volume":"142","author":"Torabi","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jclinpath-2017-204616","article-title":"Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia","volume":"71","author":"Sun","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0041","first-page":"2095","article-title":"Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues","volume":"60","author":"Narducci","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.retram.2023.103428_bib0042","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ajcp\/aqac166","article-title":"T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): a Clinicopathologic Study of 15 Cases","volume":"159","author":"Hu","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0043","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1365-2141.2000.02256.x","article-title":"T-cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation","volume":"110","author":"De Schouwer","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0044","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41467-017-02688-6","article-title":"Actionable perturbations of damage responses by TCL1\/ATM and epigenetic lesions form the basis of T-PLL","volume":"9","author":"Schrader","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2023.103428_bib0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/gcc.22821","article-title":"Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia","volume":"59","author":"Patil","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.retram.2023.103428_bib0046","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-4608(97)00410-X","article-title":"Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization","volume":"103","author":"Maljaei","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103428_bib0047","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1158\/0008-5472.CAN-21-1908","article-title":"Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia","volume":"82","author":"Braun","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.retram.2023.103428_bib0048","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/sj.leu.2404877","article-title":"Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)","volume":"21","author":"Durig","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0049","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3324\/haematol.2008.001347","article-title":"Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy","volume":"94","author":"Nowak","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0050","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2007-06-095570","article-title":"Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia","volume":"111","author":"Le Toriellec","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0051","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/cancers11121833","article-title":"JAK\/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL","volume":"11","author":"Wahnschaffe","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.retram.2023.103428_bib0052","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.13952","article-title":"Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia","volume":"173","author":"Lopez","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0053","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41408-017-0036-5","article-title":"SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia","volume":"8","author":"Johansson","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.retram.2023.103428_bib0054","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","article-title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","volume":"34","author":"Barila","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0055","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0056","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-022-00630-8","article-title":"Identification of novel STAT5B mutations and characterization of TCRbeta signatures in CD4+ T-cell large granular lymphocyte leukemia","volume":"12","author":"Bhattacharya","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.retram.2023.103428_bib0057","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41588-022-01059-2","article-title":"CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk","volume":"54","author":"Baer","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2023.103428_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081801","article-title":"Clinical Applications of Genomic Alterations in ATLL: predictive Markers and Therapeutic Targets","volume":"13","author":"Yoshida","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.retram.2023.103428_bib0059","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjh.17211","article-title":"Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia\/lymphoma","volume":"192","author":"Sakamoto","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0060","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1080\/10428194.2018.1538506","article-title":"Cytogenetic analysis of adult T-cell leukemia\/lymphoma: evaluation of a Caribbean cohort","volume":"60","author":"Sun","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2023.103428_bib0061","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ijlh.13577","article-title":"Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American adult T-cell leukemia\/lymphoma cohort","volume":"43","author":"Zhang","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.retram.2023.103428_bib0062","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0063","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1158\/0008-5472.CAN-09-2367","article-title":"Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays","volume":"69","author":"Caprini","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.retram.2023.103428_bib0064","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","article-title":"Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes","volume":"130","author":"Laharanne","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.retram.2023.103428_bib0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2023.103428_bib0066","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2023.103428_bib0067","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0068","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","article-title":"Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides","volume":"130","author":"Salgado","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.retram.2023.103428_bib0069","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000001449","article-title":"Clinical, histologic, and molecular characteristics of anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Melchers","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0070","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/cancers15164098","article-title":"Primary Cutaneous Anaplastic Large Cell Lymphoma-A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features","volume":"15","author":"Ortiz-Hidalgo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.retram.2023.103428_bib0071","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0072","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0073","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3324\/haematol.2020.263251","article-title":"Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma","volume":"107","author":"Bastidas Torres","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2020.09.013","article-title":"Outcomes of Hepatosplenic T-Cell Lymphoma: the Mayo Clinic Experience","volume":"21","author":"Bojanini","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.retram.2023.103428_bib0075","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","volume":"136","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0076","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0077","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cancergen.2018.06.003","article-title":"A rare case of hepatosplenic gammadelta T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8","volume":"228\u2013229","author":"Jain","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.retram.2023.103428_bib0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102977","article-title":"Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma","volume":"9","author":"Finalet Ferreiro","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.retram.2023.103428_bib0079","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.retram.2023.103428_bib0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and \u03b3\u03b4 T-cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0081","first-page":"227","article-title":"The non-leukemic T cell large granular lymphocytic leukemia variant with marked splenomegaly and neutropenia in the setting of rheumatoid arthritis - Felty syndrome and hepatosplenic T cell lymphoma mask","volume":"11","author":"Gorodetskiy","year":"2021","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.retram.2023.103428_bib0082","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2023.103428_bib0083","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00428-022-03467-5","article-title":"Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review","volume":"482","author":"Fan","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.retram.2023.103428_bib0084","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","author":"Sharma","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103428_bib0085","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41375-019-0678-3","article-title":"Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract","volume":"34","author":"Hu","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0086","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2019.230961","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","volume":"105","author":"Soderquist","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0087","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.humpath.2009.11.020","article-title":"Enteropathy-associated T-cell lymphoma\u2013a clinicopathologic and array comparative genomic hybridization study","volume":"41","author":"Ko","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0088","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0089","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.retram.2023.103428_bib0090","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.retram.2023.103428_bib0091","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/path.1506","article-title":"Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma","volume":"202","author":"Obermann","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0092","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.retram.2023.103428_bib0093","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PAS.0000000000001658","article-title":"Immunophenotypic spectrum and genomic landscape of refractory celiac disease type II","volume":"45","author":"Soderquist","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0094","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0095","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/modpathol.2015.85","article-title":"Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan","volume":"28","author":"Tomita","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0096","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13000-021-01173-5","article-title":"Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases","volume":"16","author":"Chen","year":"2021","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0097","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.humpath.2013.10.038","article-title":"Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan","volume":"45","author":"Kikuma","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.retram.2023.103428_bib0098","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3324\/haematol.2022.281226","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome","volume":"108","author":"Veloza","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103428_bib0099","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3748\/wjg.v18.i19.2434","article-title":"An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: a case report","volume":"18","author":"Okumura","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.retram.2023.103428_bib0100","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0101","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1042\/CS20200032","article-title":"Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis","volume":"134","author":"Vaira","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.retram.2023.103428_bib0102","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2023.103428_bib0103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10428199909050949","article-title":"Cytogenetic abnormalities in natural killer cell lymphoma\/leukaemia\u2013is there a consistent pattern?","volume":"34","author":"Wong","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2023.103428_bib0104","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/his.13463","article-title":"Aggressive natural killer (NK)-cell leukaemia and extranodal NK\/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings","volume":"72","author":"Yang","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.retram.2023.103428_bib0105","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41375-022-01623-z","article-title":"Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer\/T-cell lymphoma","volume":"36","author":"Dong","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103428_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.retram.2023.103428_bib0107","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1080\/1042819031000119217","article-title":"Phytohemagglutinin inhibits lymphoid tumor growth in vitro and in vivo","volume":"44","author":"D'Costa","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2023.103428_bib0108","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.1995.tb05587.x","article-title":"The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage","volume":"90","author":"Shimodaira","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103428_bib0109","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:42:31Z","timestamp":1762821751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2452318623000521"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103428","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103428"}}